Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2002-10-21
pubmed:abstractText
Vasoactive intestinal peptide (VIP) functions as a neurotransmitter involved in a number of physiological and pathological conditions. The actions of VIP are mediated through VPAC(1) and VPAC(2). In contrast to VPAC(1), which has been extensively studied, little is known about the pharmacology of VPAC(2). In this study we investigated the VIP pharmacophore for VPAC(2) by using alanine and D-amino acid scanning. We found significant species differences, and the human VPAC(2) (hVPAC(2)) expressed in Chinese hamster ovary (CHO) cells, which have been used in previous studies, differed significantly from the native hVPAC(2) in Sup T(1) cells and hVPAC(2) expressed in PANC1 cells. There was a close agreement between binding affinities and potencies for VPAC(2) activation. The amino acids whose backbone or side chain orientations were most important for high affinity potency are Asp(3), Phe(6), Thr(7), Tyr(10), Arg(12), Tyr(22), and Leu(23), whereas the side chains of Ser(2), Asp(8), Asn(9), Gln(16), Val(19), Lys(20), Lys(21), Asn(24), and Ser(25) are not essential. Comparison of the VIP pharmacophore between hVPAC(1) and hVPAC(2) demonstrated that the side chains of Thr(7), Tyr(10), Thr(11), and Tyr(22) were much more critical for high affinity for the hVPAC(2) than the hVPAC(1). In contrast, the orientation of the side chain of Asn(24) was more important for high affinity for the hVPAC(1). This study shows that in assessing the pharmacophore of VIP analogs for the VPAC(2), important species differences need to be considered as well as the expression system used. These results of our study should be useful for designing VPAC subtype-selective analogs, simplified analogs, and possibly metabolically stable analogs.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adenylate Cyclase, http://linkedlifedata.com/resource/pubmed/chemical/Alanine, http://linkedlifedata.com/resource/pubmed/chemical/Amino Acids, http://linkedlifedata.com/resource/pubmed/chemical/Iodine Radioisotopes, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vasoactive Intestinal..., http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vasoactive Intestinal..., http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vasoactive Intestinal..., http://linkedlifedata.com/resource/pubmed/chemical/Ro 25-1553, http://linkedlifedata.com/resource/pubmed/chemical/Vasoactive Intestinal Peptide
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
303
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
445-60
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12388623-Adenylate Cyclase, pubmed-meshheading:12388623-Alanine, pubmed-meshheading:12388623-Amino Acid Sequence, pubmed-meshheading:12388623-Amino Acid Substitution, pubmed-meshheading:12388623-Amino Acids, pubmed-meshheading:12388623-Animals, pubmed-meshheading:12388623-CHO Cells, pubmed-meshheading:12388623-Cricetinae, pubmed-meshheading:12388623-Humans, pubmed-meshheading:12388623-Iodine Radioisotopes, pubmed-meshheading:12388623-Molecular Sequence Data, pubmed-meshheading:12388623-Peptides, pubmed-meshheading:12388623-Peptides, Cyclic, pubmed-meshheading:12388623-Rats, pubmed-meshheading:12388623-Receptors, Vasoactive Intestinal Peptide, pubmed-meshheading:12388623-Receptors, Vasoactive Intestinal Peptide, Type II, pubmed-meshheading:12388623-Receptors, Vasoactive Intestinal Polypeptide, Type I, pubmed-meshheading:12388623-T-Lymphocytes, pubmed-meshheading:12388623-Transfection, pubmed-meshheading:12388623-Tumor Cells, Cultured, pubmed-meshheading:12388623-Vasoactive Intestinal Peptide
pubmed:year
2002
pubmed:articleTitle
Elucidation of the vasoactive intestinal peptide pharmacophore for VPAC(2) receptors in human and rat and comparison to the pharmacophore for VPAC(1) receptors.
pubmed:affiliation
Digestive Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases/NIH, Building 10, 10 Center Drive, Bethesda, MD 20892, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S.